Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.
暂无分享,去创建一个
P. Wesseling | P. Verweij | A. Rijs | R. Klont | C. Eggink
[1] B. Odhav,et al. Mycotic keratitis: profile of Fusarium species and their mycotoxins , 2004, Mycoses.
[2] J. Perfect,et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] P. Wesseling,et al. Keratitis Caused by Scedosporium apiospermum Successfully Treated with a Cornea Transplant and Voriconazole , 2003, Journal of Clinical Microbiology.
[4] M. Shanmugam,et al. Spontaneous venous pulsations should be monitored during glaucoma therapy , 2002, The British journal of ophthalmology.
[5] J. Peter,et al. Testing Conditions for Determination of Minimum Fungicidal Concentrations of New and Established Antifungal Agents for Aspergillus spp.: NCCLS Collaborative Study , 2002, Journal of Clinical Microbiology.
[6] M. Araie,et al. Do climatic variables influence the development of posterior vitreous detachment? , 2002, The British journal of ophthalmology.
[7] A. Espinel-Ingroff. In Vitro Fungicidal Activities of Voriconazole, Itraconazole, and Amphotericin B against Opportunistic Moniliaceous and Dematiaceous Fungi , 2001, Journal of Clinical Microbiology.
[8] K. Tintelnot,et al. Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole , 2000, The British journal of ophthalmology.
[9] M. Rinaldi,et al. Comparison of High-Performance Liquid Chromatographic and Microbiological Methods for Determination of Voriconazole Levels in Plasma , 2000, Antimicrobial Agents and Chemotherapy.
[10] S. Gupta,et al. Ocular atopy and mycotic keratitis. , 1990, Annals of ophthalmology.
[11] Judy E. Kim,et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. , 2004, Archives of ophthalmology.